RPG Life Sciences subsidiary completes Raghava Life Sciences API business acquisition

Listed-company acquisitionStrategic Transactions View source PDF Explain this filing

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹2770.00

prior close

₹2691.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-0.9% vs market

Pharmaceuticals peers, median of 173sector-0.3%-0.7% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+0.5

15m

-0.4

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0-0.1-0.9-0.3-0.7

Next day

+1.5+0.7+0.8+0.6+1.0

+0.8+2.3-1.6+1.5-0.8

-0.3+2.2-2.5+1.6-1.9

-0.4+2.6-3.0+1.9-2.2

+9.6+3.9+5.7+2.5+7.1

+10.3+2.7+7.6+0.8+9.5

15d

+2.2-1.2+3.4-3.3+5.4

+5.6-0.2+5.8-3.9+9.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

RPG Life Sciences' wholly owned subsidiary RPG Active Pharma has completed the acquisition of the Active Pharmaceutical Ingredients (API) and intermediates business from Raghava Life Sciences Private Limited via slump sale. The transfer is effective September 16, 2026. This follows the earlier BTA execution announcement dated September 2, 2026.

Likely market impact

Expands the RPG group's API and intermediates business through subsidiary acquisition, effective September 16, 2026.